Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Benefit of Treatment With Sebelipase-Alfa in a 63-Year-Old Patient With Advanced Liver and Atherosclerotic Disease Due to Lysosomal Acid Lipase Deficiency (LAL-D)

Aigner, Elmar MD1; Feldman, Alexandra MD1; Neureiter, Daniel MD2; Datz, Christian MD3; Ratziu, Vlad MD4; Paulweber, Bernhard MD1

American Journal of Gastroenterology: March 2018 - Volume 113 - Issue 3 - p 443–445
doi: 10.1038/ajg.2017.486
LETTERS TO THE EDITOR
Buy

1First Department of Medicine, Paracelsus Medical University Salzburg, Salzburg, Austria

2Department of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria

3Department of Internal Medicine, Oberndorf Hospital, Salzburg, Austria

4Hospital Pitié-Salpêtrière, Institute of Cardiometabolism and Nutrition, Sorbonne Universités, Paris, France

Correspondence: Elmar Aigner, MD, First Department of Medicine, Paracelsus Medical University Salzburg, Austria, Mìllner Hauptstrasse 48, Salzburg 5020, Austria. E-mail: e.aigner@salk.at

© The American College of Gastroenterology 2018. All Rights Reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website